The association of heart failure with insulin resistance and the development of type 2 diabetes

American Journal of Hypertension

Volumn 18, Issue 5, 2005, Pages 731-737

  Kostis, John B ^a,b   Sanders, Michael ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Diabetes; Heart failure; Vasodilation; blockers

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CELIPROLOL; DILEVALOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL; PINDOLOL; PROPRANOLOL; THIAZIDE DIURETIC AGENT; TIMOLOL; VERAPAMIL;

ADIPOSE TISSUE; ADRENERGIC SYSTEM; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETOGENESIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; GLUCOSE METABOLISM; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; LIPOLYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 18844362383     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.11.038     Document Type: Review

References (73)

1. G. Paolisso, S. De Riu, G. Marrazzo, M. Verza, M. Varricchio, F. D'Onofrio Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure Metabolism 40 1991 972 977
2. M. Bobbio, S. Ferrua, C. Opasich, M. Porcu, D. Lucci, M. Scherillo, L. Tavazzi, A.P. Maggioni Survival and hospitalization in heart failure patients with or without diabetes treated with β-blockers J Card Fail 9 2003 192 202
3. A.H. Mokdad, B.A. Bowman, E.S. Ford, F. Vinicor, J.S. Marks, J.P. Koplan The continuing epidemics of obesity and diabetes in the United States JAMA 286 2001 1195 1200
4. N. Suskin, R.S. McKelvie, R.J. Burns, R. Latini, D. Pericak, J. Probstfield, J.L. Rouleau, C. Sigouin, C.B. Solymoss, R. Tsuyuki, M. White, S. Yusuf Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure Eur Heart J 21 2000 1368 1375
5. E. Vermes, A. Ducharme, M.G. Bourassa, M. Lessard, M. White, J.C. Tardif Enalapril reduces the incidence of diabetes in patients with chronic heart failure insight from the Studies Of Left Ventricular Dysfunction (SOLVD) Circulation 107 2003 1291 1296
6. T.B. Levine, G.S. Francis, S.R. Goldsmith, A.B. Simon, J.N. Cohn Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure Am J Cardiol 49 1982 1659 1666
7. A.G. Marangou, F.P. Alford, G. Ward, F. Liskaser, P.M. Aitken, K.M. Weber, R.C. Boston, J.D. Best Hormonal effects of norepinephrine on acute glucose disposal in humans a minimal model analysis Metabolism 37 1988 885 891
8. M.F. Saad, W.C. Knowler, D.J. Pettitt, R.G. Nelson, M.A. Charles, P.H. Bennett A two-step model for development of non-insulin-dependent diabetes Am J Med 90 1991 229 235
9. B.J. Goldstein Insulin resistance as the core defect in type 2 diabetes mellitus Am J Cardiol 90 2002 3G 10G
10. J.W. Swan, C. Walton, I.F. Godsland, A.L. Clark, A.J. Coats, M.F. Oliver Insulin resistance in chronic heart failure Eur Heart J 15 1994 1528 1532
11. R.A. DeFronzo, R.C. Bonadonna, E. Ferrannini Pathogenesis of NIDDM. A balanced overview Diabetes Care 15 1992 318 368
12. D. Porte Jr Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications Diabetes Metab Res Rev 17 2001 181 188
13. A.E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R.A. Rizza, P.C. Butler β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes Diabetes 52 2003 102 110
14. E. Ferrannini Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus problems and prospects Endocrinol Rev 19 1998 477 490
15. E. Cerasi, N. Kaiser, G. Leibowitz Type 2 diabetes and β cell apoptosis Diabetes Metab 26 Suppl 3 2000 13 16
16. T.J. Wilkin The accelerator hypothesis weight gain as the missing link between type I and type II diabetes Diabetologia 44 2001 914 922
17. A. Moran, H.J. Zhang, L.K. Olson, J.S. Harmon, V. Poitout, R.P. Robertson Differentiation of glucose toxicity from β cell exhaustion during the evolution of defective insulin gene expression in the pancreatic islet cell line, HIT-T15 J Clin Invest 99 1997 534 539
18. Y. Lee, H. Hirose, M. Ohneda, J.H. Johnson, J.D. McGarry, R.H. Unger β-Cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats impairment in adipocyte-β-cell relationships Proc Natl Acad Sci USA 91 1994 10878 10882
19. M. Shimabukuro, Y.T. Zhou, Y. Lee, R.H. Unger Troglitazone lowers islet fat and restores β cell function of Zucker diabetic fatty rats J Biol Chem 273 1998 3547 3550
20. S.E. Kahn, S. Andrikopoulos, C.B. Verchere Islet amyloid a long-recognized but underappreciated pathological feature of type 2 diabetes Diabetes 48 1999 241 253
21. E. Araki, S. Oyadomari, M. Mori Impact of endoplasmic reticulum stress pathway on pancreatic β-cells and diabetes mellitus Exp Biol Med (Maywood) 228 2003 1213 1217
22. P. Palatini, S. Julius Association of tachycardia with morbidity and mortality pathophysiological considerations J Hum Hypertens 11 Suppl 1 1997 S19 S27
23. J.W. Swan, S.D. Anker, C. Walton, I.F. Godsland, A.L. Clark, F. Leyva, J.C. Stevenson, A.J. Coats Insulin resistance in chronic heart failure relation to severity and etiology of heart failure J Am Coll Cardiol 30 1997 527 532
24. A. Festa, R. D'Agostino Jr, C.N. Hales, L. Mykkanen, S.M. Haffner Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects Diabetes Care 23 2000 624 628
25. P. Palatini, E. Casiglia, P. Pauletto, J. Staessen, N. Kaciroti, S. Julius Relationship of tachycardia with high blood pressure and metabolic abnormalities a study with mixture analysis in three populations Hypertension 30 1997 1267 1273
26. P. Palatini Sympathetic overactivity in hypertension a risk factor for cardiovascular disease Curr Hypertens Rep 3 Suppl 1 2001 S3 S9
27. M.R. Carnethon, S.H. Golden, D. Liao Autonomic nervous system dysfunction and diabetes Cardiol Rev 20 2003 36 40
28. T. Pollare, H. Lithell, I. Selinus, C. Berne Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension Diabetologia 31 1988 415 420
29. T.B. Ng Adrenergic control of lipolysis in adipocytes of several mammalian species Comp Biochem.Physiol C 82 1985 463 466
30. J.N. Cohn, T.B. Levine, M.T. Olivari, V. Garberg, D. Lura, G.S. Francis, A.B. Simon, T. Rector Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 1984 819 823
31. L. Benthem, K. Keizer, C.H. Wiegman, S.F. de Boer, J.H. Strubbe, A.B. Steffens, F. Kuipers, A.J. Scheurink Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation Am J Physiol Endocrinol Metab 279 2000 E1286 E1293
32. G. Paolisso, P.A. Tataranni, J.E. Foley, C. Bogardus, B.V. Howard, E. Ravussin A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM Diabetologia 38 1995 1213 1217
33. G. Boden Free fatty acids, insulin resistance, and type 2 diabetes mellitus Proc Assoc Am Physicians 111 1999 241 248
34. P.J. Randle, D.A. Priestman, S. Mistry, A. Halsall Mechanisms modifying glucose oxidation in diabetes mellitus Diabetologia 37 Suppl 2 1994 S155 S161
35. G. Paolisso, A. Gambardella, D. Galzerano, A. D'Amore, P. Rubino, M. Verza, P. Teasuro, M. Varricchio, F. D'Onofrio Total-body and myocardial substrate oxidation in congestive heart failure Metabolism 43 1994 174 179
36. M.R. Hayden, S.C. Tyagi Myocardial redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and congestive heart failure Med Sci Monit 9 2003 SR35 SR52
37. U. Scherrer, C. Sartori Insulin as a vascular and sympathoexcitatory hormone implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity Circulation 96 1997 4104 4113
38. S. Vehkavaara, A. Seppala-Lindroos, J. Westerbacka, P.H. Groop, H. Yki-Jarvinen In vivo endothelial dysfunction characterizes patients with impaired fasting glucose Diabetes Care 22 1999 2055 2060
39. L. Amato, G. Paolisso, F. Cacciatore, N. Ferrara, P. Ferrara, S. Canonico, M. Varricchio, F. Rengo Congestive heart failure predicts the development of non-insulin- dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group Diabetes Metab 23 1997 213 218
40. S. Yusuf, M.A. Pfeffer, K. Swedberg, C.B. Granger, P. Held, J.J. McMurray, E.L. Michelson, B. Olofsson, J. Ostergren Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction the CHARM-Preserved Trial Lancet 362 2003 777 781
41. S. Jacob, K. Rett, E.J. Henriksen Antihypertensive therapy and insulin sensitivity do we have to redefine the role of β-blocking agents? Am J Hypertens 11 1998 1258 1265
42. H. Lithell, T. Pollare, B. Vessby Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients Blood Press 1 1992 92 101
43. A. Haenni, H. Lithell Treatment with a β-blocker with β 2-agonism improves glucose and lipid metabolism in essential hypertension Metabolism 43 1994 455 461
44. S. Jacob, K. Rett, M. Wicklmayr, B. Agrawal, H.J. Augustin, G.J. Dietze Differential effect of chronic treatment with two β-blocking agents on insulin sensitivity the carvedilol-metoprolol study J Hypertens 14 1996 489 494
45. T. Pollare, H. Lithell, C. Morlin, H. Prantare, A. Hvarfner, S. Ljunghall Metabolic effects of diltiazem and atenolol results from a randomized, double-blind study with parallel groups J Hypertens 7 1989 551 559
46. T. Pollare, H. Lithell, I. Selinus, C. Berne Sensitivity to insulin during treatment with atenolol and metoprolol a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients BMJ 198 1989 1152 1157
47. T.W. Gress, F.J. Nieto, E. Shahar, M.R. Wofford, F.L. Brancati Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study N Engl J Med 342 2000 905 912
48. O. Samuelsson, T. Hedner, G. Berglund, B. Persson, O.K. Andersson, L. Wilhelmsen Diabetes mellitus in treated hypertension incidence, predictive factors and the impact of non-selective β-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in the Primary Prevention Trial Goteborg, Sweden J Hum Hypertens 8 1994 257 263
49. P.G. Shekelle, M.W. Rich, S.C. Morton, S.W. Atkinson, W. Tu, M. Maglione, S. Rhodes, M. Barrett, G.C. Fonarow, B. Greenberg, P. Heidenreich, T. Knabel, M. Konstam, A. Steimle, L. Warner Stevenson Ventricular systolic dysfunction according to race, sex, and diabetic status a meta-analysis of major clinical trials J Am Coll Cardiol 41 2003 1529
50. C.J. Pepine, E.M. Handberg, R. Cooper-DeHoff, R.G. Marks, P.R. Kowey, F.H. Messerli, G. Mancia, J.L. Cangiano, D. Garcia-Barreto, M. Keltai, S. Erdine, H.A. Bristol, H.R. Kolb, G.L. Bakris, J.D. Cohen, W.W. Parmley A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the international verapamil-trandolapril study (INVEST): a randomized controlled trial JAMA 290 2003 2805 2816
51. S.W. Rabkin Mechanisms of action of adrenergic receptor blockers on lipids during antihypertensive drug treatment J Clin Pharmacol 33 1993 286 291
52. P.A. Poole-Wilson, K. Swedberg, J.G. Cleland, A. Di Lenarda, P. Hanrath, M. Komajda, J. Lubsen, B. Lutiger, M. Metra, W.J. Remme, C. Torp-Pedersen, A. Scherhag, A.M. Skene Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET) randomised controlled trial Lancet 362 2003 7 13
53. C. Torp-Pedersen, J.G. Cleland, M. Metra, A. Di Lenarda, P. Poole-Wilson, P. Hanrath, M. Komajda, J. Lubsen, B. Lutiger, W.J. Remme, A. Scherhag, A. Charlesworth Effect of Long-Term Treatment with Carvedilol Compared to Metoprolol on Heart Failure Morbidity and Diabetes in COMET J Am Coll Cardiol 2004 43 Presented at the American College of Cardiology (ACC) 53rd Annual Scientific Sessions; March 7-10, 2004; New Orleans, LA.
54. M. Gheorghiade, R.O. Bonow Chronic heart failure in the United States a manifestation of coronary artery disease Circulation 97 1998 282 289
55. S.M. Haffner, H. Miettinen Insulin resistance implications for type II diabetes mellitus and coronary heart disease Am J Med 103 1997 152 162
56. D.S.H. Bell Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease? Diabetes Care 18 1995 708 714
57. P.J. Lewis, E.M. Kohner, A. Petrie, C.T. Dollery Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment Lancet 1 1976 564 566
58. C. Bengtsson, G. Blohme, L. Lapidus, L. Lissner, H. Lundgren Diabetes incidence in users and non-users of antihypertensive drugs in relation to serum insulin, glucose tolerance and degree of adiposity a 12-year prospective population study of women in Gothenburg, Sweden J Intern Med 231 1992 583 588
59. P.A. Morales, B.D. Mitchell, R.A. Valdez, H.P. Hazuda, M.P. Stern, S.M. Haffner Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study Diabetes 42 1993 154 161
60. J.H. Gurwitz, R.L. Bohn, R.J. Glynn, M. Monane, H. Mogun, J. Avorn Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus Ann Intern Med 118 1993 273 278
61. H. Taegtmeyer, P. McNulty, M.E. Young Adaptation and maladaptation of the heart in diabetes: Part I: general concepts Circulation 105 2002 1727 1733
62. A. Genda, S. Mizuno, S. Nunoda, A. Nakayama, Y. Igarashi, N. Sugihara, M. Namura, R. Takeda, H. Bunko, K. Hisada Clinical studies on diabetic myocardial disease using exercise testing with myocardial scintigraphy and endomyocardial biopsy Clin Cardiol 9 1986 375 382
63. J. Liu, M.R. Masurekar, D.E. Vatner, G.N. Jyothirmayi, T.J. Regan, S.F. Vatner, L.G. Meggs, A. Malhotra Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart Am J Physiol Heart Circ Physiol 285 2003 H2587 H2591
64. D. Grimm, H.C. Jabusch, P. Kossmehl, M. Huber, S. Fredersdorf, D.P. Griese, B.K. Kramer, E.P. Kromer Experimental diabetes and left ventricular hypertrophy effects of β-receptor blockade Cardiovasc Pathol 11 2002 229 237
65. G.F. Avendano, R.K. Agarwal, R.I. Bashey, M.M. Lyons, B.J. Soni, G.N. Jyothirmayi, T.J. Regan Effects of glucose intolerance on myocardial function and collagen-linked glycation Diabetes 48 1999 1443 1447
66. G.R. Norton, G. Candy, A.J. Woodiwiss Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats Circulation 93 1996 1905 1912
67. R. Yarom, H. Zirkin, G. Stammler, A.G. Rose Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material J Pathol 166 1992 265 270
68. R. Marfella, K. Esposito, F. Nappo, M. Siniscalchi, F.C. Sasso, M. Portoghese, M.P. Di Marino, A. Baldi, S. Cuzzocrea, C. Di Filippo, G. Barboso, F. Baldi, F. Rossi, M. D'Amico, D. Giugliano Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes Diabetes 53 2004 2383 2391
69. I. Juhan-Vague, P. Vague, C. Poisson, M.F. Aillaud, C. Mendez, D. Collen Effect of 24 hours of normoglycaemia on tissue-type plasminogen activator plasma levels in insulin-dependent diabetes Thromb Haemost 51 1984 97 98
70. R.P. Gray, J.S. Yudkin, D.L. Patterson Plasminogen activator inhibitor a risk factor for myocardial infarction in diabetic patients Br Heart J 69 1993 228 232
71. B. Telejko, A. Zonenberg, I. Borejszo, I. Kinalska Some parameters of hemostasis and fibrinolysis in diabetic patients Pol Arch Med Wewn 100 1998 133 138
72. D. Vinereanu, E. Nicolaides, A.C. Tweddel, C.F. Madler, B. Holst, L.E. Boden, M. Cinteza, A.E. Rees, A.G. Fraser Subclinical left ventricular dysfunction in asymptomatic patients with type II diabetes mellitus, related to serum lipids and glycated haemoglobin Clin Sci (Lond) 105 2003 591 599
73. M.F. Oliver, L.H. Opie Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias Lancet 343 1994 155 158